OXBRIDGE RE HOLDINGS LtdOXBR
| Dec 31, 2014 | Dec 31, 2015 | Dec 31, 2016 | Dec 31, 2017 | Dec 31, 2018 | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 |
|---|
| Net loss attributable to ordinary shareholders | 4 | 5 | 3 | -21 | -6 | -0 | -0 | -9 | -2 | -10 | -3 |
|---|
| Share-based compensation | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
|---|
| Depreciation and amortization | - | - | - | - | - | - | - | - | 0 | 0 | 0 |
|---|
| Interest and gain on redemption of Series A-1 preferred shares | - | - | - | - | - | - | - | - | - | - | 0 |
|---|
| Interest and gain on redemption of loan receivable | - | - | - | - | - | - | - | - | - | - | 0 |
|---|
| SurancePlus fee income | - | - | - | - | - | - | - | - | - | 0 | 0 |
|---|
| Change in fair value of equity securities | - | - | - | - | - | - | - | - | - | 0 | -0 |
|---|
| Unrealized loss on other investments | - | - | - | - | 0 | -0 | - | 9 | -0 | -9 | -2 |
|---|
| Income attributable to non-controlling interests | - | - | - | - | - | - | - | - | - | 1 | 0 |
|---|
| Premiums receivable | 4 | 0 | -0 | -0 | -4 | 1 | -0 | 0 | -0 | 1 | 0 |
|---|
| Due from related parties | - | - | - | - | - | - | - | 0 | 0 | 0 | -0 |
|---|
| Deferred policy acquisition costs | 0 | -0 | -0 | -0 | -0 | 0 | -0 | -0 | -0 | 0 | 0 |
|---|
| Prepayment and other assets | 0 | 0 | 0 | 0 | -0 | 0 | -0 | -0 | 0 | -0 | -0 |
|---|
| Prepaid offering costs | - | - | - | - | - | - | - | - | 0 | -0 | - |
|---|
| Other Liabilities CatRe Tokenholders | - | - | - | - | - | - | - | - | - | 1 | -1 |
|---|
| Losses payable | - | - | - | - | - | - | - | - | 1 | -1 | - |
|---|
| Unearned premiums reserve | 4 | -0 | -2 | -1 | -2 | 0 | -0 | -0 | -0 | 1 | 0 |
|---|
| Accounts payable and other liabilities | -0 | 0 | 0 | -0 | 0 | 0 | -0 | 0 | -0 | 0 | 0 |
|---|
| Net cash used in operating activities | - | - | - | - | - | - | - | -0 | -1 | -1 | -1 |
|---|
| Proceeds (funding) of loan receivable | - | - | - | - | - | - | - | - | - | - | -0 |
|---|
| Proceeds on redemption of Series A-1 preferred stock | - | - | - | - | - | - | - | - | - | - | 0 |
|---|
| Proceeds from sale of equity securities | - | - | - | - | - | - | - | - | 1 | - | 0 |
|---|
| Purchase of property and equipment | 0 | 0 | 0 | 0 | - | 0 | 0 | 0 | - | 0 | - |
|---|
| Net cash provided by (used in) investing activities | - | - | - | - | - | - | - | -2 | -1 | -0 | 1 |
|---|
| Net proceeds from issuance of ordinary shares | 0 | - | - | - | - | - | - | - | - | - | 1 |
|---|
| Partial redemption of notes payable to noteholders | - | - | - | - | - | - | - | - | - | 98,000 | - |
|---|
| Gross proceeds from the issuance of Epsilon / DeltaCat Re tokens | - | - | - | - | - | - | - | - | - | 1 | 1 |
|---|
| Net cash provided by financing activities | - | - | - | - | - | - | - | - | - | 1 | 3 |
|---|
| Net change during the year | - | - | - | - | - | - | - | - | -1 | -0 | 2 |
|---|
| Reclassification of contributed non-controlling interest | - | - | - | - | - | - | - | - | - | - | 0 |
|---|
| Right-of-use lease asset obtained in exchange for operating lease liabilities | - | - | - | - | - | - | - | - | - | - | 0 |
|---|